- Fee assured
- Verified this account
I was appointed as a consultant Haemato-oncologist at East Kent Hospitals University Foundation Trust in September 2010 having completed my specialist training on the King's College Hospital London rotation.
My special interest is in myeloma, Waldenstroms macroglobulinemia and other Lymphomas.
I actively participate in cancer research, particularly in myeloma - I am principle investigator for a number of myeloma studies run at East Kent.
Areas of interest
Current NHS consultant posts held
Kent and Canterbury Hospital
Myeloma, Waldenstrom's macroglobulinaemia
(Additional) Languages spoken
- Czech - Native or bilingual
McTaggart MP, Lindsay J, Kearney EM. Urine Protein Electrophoresis With Serum Free Light Chain Analysis as a First-Line Test for Detecting Plasma Cell Disorders Offers Increased Diagnostic Accuracy and Potential Health Benefit to Patients. Am J Clin Pathol. 2013 Dec;140(6):890-7
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.
Jones JR, Cairns DA, Gregory WM, Collett C, Pawlyn C, Sigsworth R, Striha A, Henderson R, Kaiser MF, Jenner M, Cook G, Russell NH, Williams C, Pratt G, Kishore B, Lindsay J, Drayson MT, Davies FE, Boyd KD, Owen RG, Jackson GH, Morgan GJ.
Blood Cancer J. 2016 Dec 9;6(12):e506. doi: 10.1038/bcj.2016.114.
- MUDr Charles University Prague 1997
Reference number 5206092
Professional bodies (positions held - last 3 yrs)
- FRCPath Royal College of Pathologists 2010
- FRCP Royal College of Physicians 2014